手性有机小分子路易斯碱催化剂的设计、合成及其在亚胺不对称还原中的应用

手性胺是合成天然产物和手性药物的重要中间体，亚胺的不对称催化还原是制备光学活性手性胺的最直接有效的方法之一。但是，由于C＝N双键的反应活性较弱以及容易发生E/Z异构等问题，亚胺的不对称催化还原具有很大的挑战性，既具有高对映选择性又具有宽广底物普适性的催化剂很少。 本文分别由手性脯氨酸、哌啶酸、哌嗪酸以及氨基醇出发，设计和合成了一系列结构新颖、合成简便、性能优良的酰胺类有机小分子路易斯碱催化剂，以廉价的三氯氢硅为氢源，用这些催化剂催化亚胺不对称还原，得到了非常优良的收率、对映选择性和前所未有的底物普适性。 文献研究认为，除N-甲酰基外，分子内含有芳香酰胺是能催化亚胺还原的有机小分子路易斯碱催化剂具有较高对映选择性的必要条件，我们研究发现N-甲酰脯氨酸非芳香酰胺类催化剂（包括结构简单的C2-对称型脯氨酰胺类催化剂），对N-芳基酮亚胺的还原可获得达86%的对映选择性，远高于同类芳香酰胺催化剂，证明N-甲酰非芳香酰胺类路易斯碱催化剂在亚胺还原中也能得到高的对映选择性。 在进一步研究中，我们以手性六元哌啶酸为模板，分别设计合成了N-甲酰哌啶酸芳香酰胺和N-甲酰哌啶酸非芳香酰胺两类催化剂，其中芳香酰胺催化剂（S）-N-（甲酰基）哌啶-2-酸-1-萘基酰胺（28）和非芳香酰胺催化剂（2S,1'S,2'S）-N-（甲酰基）-哌啶-2-酸（1',2'-二苯基-2'-乙酰氧基-乙基）酰胺（30）显示出非常优良的催化活性和对映选择性，对于N-芳基芳香酮亚胺的还原，无论是缺电子体系还是富电子体系，绝大部分都能得到很高的收率（达98%）和对映选择性（达96% ee)。特别值得一提的是30对一些脂肪族亚胺和α,β-不饱和亚胺的还原，虽然底物为E/Z混合物，也能得到很高的收率（达93%）和对映选择性（达95% ee)，这样的底物普适性在过渡金属催化体系中也是前所未有的。 现有的催化亚胺还原的高对映选择性催化体系大多仅适用于甲基酮亚胺底物，对位阻较大的非甲基酮亚胺很难获得好的结果。我们以L-哌嗪酸为模板设计和合成出的（S）-N-（甲酰基）-哌嗪-2-酸-4-对叔丁基苯磺酰基-苯基酰胺不但对N-芳基甲基酮亚胺有很好的对映选择性（达90% ee)，而且对于大位阻的N-芳基非甲基酮亚胺有更好的对映选择性（达97% ee)。该催化剂与30在底物普适性方面具有很好的互补性。 我们还设计了基于1,2-二苯基氨基醇为模板的新型N-甲酰路易斯碱有机小分子催化剂，首次发现结构简单的N-甲酰（1S,2R）二苯基氨基醇能较好的催化N-芳基酮亚胺，最高可以得到82%的对映选择性。 针对我们设计合成的结构新颖、性能优良的催化剂，我们对催化机理进行了探讨和解释，提出了几个假想的机理模型。 Catalytic enantioselective reduction of imines represents one of the most straightforward and efficient methods for the preparation of chiral amines, an important intermediate for the synthesis of natural products and chiral drugs. However, asymmetric reduction of imines remains a big challenge and highly enantioselective catalysts with a satisfactorily broad substrate scope remain elusive. Factors contributing to the difficulty of this transformation include the weak reactivity of the C=N bond and the existence of inseparable mixtures of E/Z isomers. Starting from chiral proline, pipecolinic acid, piperazine-2-carboxylic acid and 1,2-diphenyl amino alcohol, a series of structurally simple and easily prepared amides were developed as highly effective Lewis basic organocatalysts for the asymmetric reduction of imines with trichlorosilane as the reducing agent, which promoted the reduction of N-aryl imines with high yields and excellent enantioselectivities with an unprecedented substrate spectrum. In the literature, it has been believed that besides the N-formyl group, the existence of an arylamido group in the structure of Lewis basic organocatalysts is a prerequisite for obtaining high enantioselectivity in the catalytic reduction of imines. However, we found that the N-formyl-L-prolinamides bearing non-arylamido groups, including structurally simple C2-symmetric tetraamides, could also work as effective Lewis basic catalysts to promote the asymmetric reduction of ketimines with high enantioselectivities (up to 86% ee), which are even more enantioselective than the analogues with arylamido groups. In further studies, we developed novel N-formamides with arylamido groups and non-arylmido groups as Lewis basic catalysts using the commercially available L-pipecolinic acid as the template. The catalysts (S)-1-formyl-piperidine-2-carboxylic acid naphthylamide 28 and (2S,1'S,2'S)-acetic acid 2-[(1-formyl-piperidine-2-carbonyl) -amino]-1,2-diphenyl-ethyl ester 30 were found to promote the reduction of a broad range of N-aryl imines in high yields (up to 98%) and excellent ee values (up to 96%) under mild conditions. Furthermore, catalyst 30 also exhibited high enantioselectivities (up to 95% ee) for the challenging aliphatic ketimines and α,β-unsaturated imines despite that these imines exist as E/Z isomeric mixtures. The broad substrate spectrum of this catalyst is unprecedented in catalytic asymmetric imine reduction, including transition-metal-catalyzed hydrogenation processes. Many of the currently available highly enantioselective catalytic systems only tolerate methyl ketimines, which gave poor results for bulkier non-methyl ketimines. Starting from L-piperazine-2-carboxylic acid, we developed (S)-4-(4-tert- butylbenzenesulfonyl)-1-formyl-N-phenyl-piperazine-2-carboxamide as highly enantioselective Lewis basic catalysts for the hydrosilylation of both methyl ketimines and steric bulky non-methyl ketimines. Moreover, higher enantioselectivities were obtained for non-methyl ketimines than methyl ketimines under the catalysis of this catalyst. Thus, this catalyst system complements with 30 in terms of the substrate scope. We also found that easily accessible (1R,2S)-N-formyl-1,2-diphenyl- 2-aminoethanol worked as an effective Lewis basic catalyst in the enantioselective hydrosilylation of ketimines, affording high enantioselectivities (up to 82% ee) for a broad range of ketimines. To rationalize the high efficiencies of the structurally novel catalysts we developed, several catalytic models have been proposed.

N-烷基氮杂糖及其衍生物的合成

多羟基哌啶类化合物通常称为氮杂糖，由于与糖结构的相似性，亚胺基环醇表现出强的糖苷酶和糖基转移酶抑制活性，可调控在生物识别及酶结构控制中起到重要作用的糖蛋白的生物合成与水解。因此这类抑制剂有望成为与糖代谢紊乱有关的疾病的治疗药物，如：抗糖尿病、抗肿瘤、抗溶酶体贮积症及抗病毒感染（包括艾滋病）等药物。正是由于氮杂糖的重要生物活性及诱人的药用开发前景，近年来，有关氮杂糖及其衍生物的合成、生物活性及应用研究备受关注。 本论文探索了一系列的作为潜在的迈克加成中间体1-C-乙酰甲基/甲氧羰基甲基-5-N-取代呋喃核糖碳苷衍生物在碱的作用下先发生β-消除反应，接着发生分子内的迈克加成反应生成1-C-乙酰甲基-N-取代氮杂吡喃糖碳苷衍生物及1-C-甲氧羰基甲基-N-取代氮杂吡喃糖碳苷衍生物的方法，该转变过程为先通过β-消除得到非环状的α/β不饱和共轭酮或酯的中间体，接着5-N-取代氨基与分子内的α/β不饱和共轭酮或酯发生分子内的1,4-亲核加成，其中，2'-酯的环加成立体选择性的得到β型1-C-乙酰甲基-N-取代氮杂吡喃糖碳苷衍生物，而2'-酮的环加成得到立体异构体1-C-乙酰甲基-N-取代氮杂吡喃糖碳苷衍生物。此外，该类N-取代氮杂吡喃糖碳苷衍生物进一步脱除保护基，得到了一系列新的N-取代氮杂吡喃糖衍生物，拓展了氮杂吡喃糖碳苷分子库。 中间体1-C-(2'-oxoalkyl)-5-N-alkylated glycoribofuranoside的合成是由核糖为原料，通过对其结构修饰，在C-5氮原子上先引入不同的取代基，在C-1上引入乙酰甲基或甲氧羰基甲基。C-5取代氨基的引入通过两种方法：(a) 5-取代链状脂肪氨基可由链状的伯胺直接与5-甲磺酰基发生SN2亲核取代得到；(b) 5-取代芳香氨基可通过芳香醛与C-5氨基缩合再由硼氢化钠还原得到。2'-酰基的引入通过烯丙基氧化得到：2'-酮羰基由醋酸汞和琼斯试剂氧化得到；2'-酯基由高锰酸钾氧化再碘甲烷的作用下得到。 The polyhydroxylated piperidines, commonly be called azasugars. Iminocyclitols and their derivatives have exhibited remarkable biological activity to inhibit glycosidase-processing enzymes, with resulting potential chemotherapeutic applications against diabetes, cancer, lysosomal storage disorders and viral infections including AIDS. Recently, because of the important biological activity and excellent foreground on pharmaceutical application, great attention has been attracted to the synthesis of the new derivatives and analogues. In this dissertation, 1-C-(2'-oxoalkyl)-5-N-substituted-glycoribofuranosides, which used as latent substrates for intramolecular hetero-Michael addition, were converted to 2-ester and 2-ketone aza-C-glycopyranosides by base treatment. The transformation was achieved through β-elimination to an acyclic α/β-conjugated ketone or ester, followed by an intramolecular hetero-Michael addition by the 5-N-alkylated amino group. The 2-ester cycloaddition was highly stereoselective in favor of an equatorial 1-C-substitution while the 2-ketone cycloaddition was produced a pair of stereoisomers of 2′-ketonyl aza-C-glycoside. Additionally, the resultant different N-alkylated aza-C-glycopyranosides could be further prepared for various azasugar library constructions by removal of protecting groups. Synthesis of the key intermediate 1-C-(2'-oxoalkyl)-5-N-alkylated glycoribo- furanoside involved the introduction of 5-substituted amino and 1-C-2′-oxoalkyl groups from D-ribose. The 5-alkylated amino was introduced through two methods: (a) the 5-aliphatic series amino synthesized by the nucleophilic substitution of 5-mesylate using neat ethylamine, propylamine, butylamine, and hexylamine, (b) the 5-aromatic series amino synthesized by various aromatic aldehydes with C-5 amino under NaBH4 reduction. The 1-C-2′-oxoalkyl groups were introduced through oxidation of the ally group: the 1-C-allyl group was oxidized with Hg(OAc)2 and Jones reagent to the 2-ketonyl C-glycoside; the 1-C-allyl group was oxidized with KMnO4 and CH3I/NaHCO3 to 1-C-methyl acetate glycoside.

厚朴中α-葡萄糖苷酶抑制活性成分研究

本论文由三章组成。 第一章是关于厚朴中具有α-葡萄糖苷酶抑制活性成分的研究。凹叶厚朴的乙醇提取物显示了较强的α-葡萄糖苷酶抑制活性。为了确定其活性成分，在活性测试的指导下，通过溶剂萃取、树脂吸附和反复硅胶柱层析等分离方法从凹叶厚朴乙醇提取物中分离得到6 个生物碱，并用质谱和核磁共振等波谱方法分别鉴定为：木兰箭毒碱，木兰花碱，鹅掌楸碱，蕃荔枝碱，罗默碱和Lysicamine。应用小肠α-葡萄糖苷酶模型测定了它们对α-葡萄糖苷酶的抑制作用。其中，番荔枝碱和木兰箭毒碱对α-葡萄糖苷酶相对抑制活性最好，分别为60%和62%；其它四个生物碱成分对α-葡萄糖苷酶的抑制活性几乎相当，鹅掌楸碱为46%，罗默碱为51%，Lysicamine 为49%，木兰花碱为51%。 第二章报道了厚朴酚的衍生物及其对α-葡萄糖苷酶的抑制活性。根据糖苷酶抑制剂的结构特点，设计合成了一系列厚朴酚的衍生物。厚朴酚经过Mannich 反应和环氧化及开环反应制备了一系列衍生物，经活性测试发现衍生物活性与取代基关系较大，其中5,5′-diallyl-3-((bis(2-hydroxyethyl)amino)methyl)biphenyl-2,2′-diol 的抑制活性最高，为72%。 第三章综述了厚朴的化学成分及药理活性两个方面的研究进展。 The dissertation consists of three chapters. The first chapter is about the study on the constituents with α-glycosidase inhibitory activity from Magnolia officinalis. The EtOH extracts of M. officinalis Rehd. et Wils showed good inhibitory activity against α-Glucosidase. In order to determine the active compounds, bio-assay was used to guide the isolation. Six known alkaloids were isolated by solvent extraction and repeated silica gel column chromatography, and their structures were identified as liriodenine, anonaine, roemerine, lysicamine, magnoflorine and magnocurarine by spectroscopic methods. The inhibitory activity against α-Glucosidase of these alkaloids was measured with alvine screening model of α-glucosidase. Among them, lysicamine and liriodenine have the best inhibitory activity at 60% and 62%, respectively. The other four alkaloids have close inhibitory activity, from 46% to 51%. The second chapter is about the derivation of magnolol and the inhibitory a ctivity of the derivatives. Seven derivatives of magnolol were prepared by Manni-ch reaction, epoxidation followed by ring-opening reaction. Biological activity as say indicated the inhibitory activity was related to substituting groups. Among them, 5,5′-diallyl-3-((bis(2-hydroxyethyl)amino)methyl)biphenyl-2,2′-diol had the highest activity at 72%. The third chapter is a review on the progress of M. officinalis including chemical constituents and pharmacological activity.